drugset / Trial / NCT03961256
Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation
RandomizedParallel-groupOpen-labelTreatment
Summary
Researchers are trying to determine if an anti-diabetes medication, called Exenatide SR, is well tolerated in kidney transplant patients with elevated blood glucose levels, and if it's effective in preventing diabetes.
Timeline
- Start
- 2019-05-09
- Primary completion
- 2021-10-18
- Completion
- 2021-10-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide SR | Unknown | 2 mg | Subcutaneous |